IGEN BIOTECH SL -  

Ranking results:

Past rankings:

2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 1
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2015 50.000 0 50.000 1
2012 0 5.975.821 331.200 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CHU HOPITAUX DE BORDEAUX1
CONSORCIO DE APOYO A LA INVESTIGACION BIOMEDICA EN RED1
DIABETES FRAIL1
HEXABIO SARL1
NICHE SCIENCE & TECHNOLOGY1
SECONDA UNIVERSITA DEGLI STUDI DI NAPOLI1
SERVICIO MADRILENO DE SALUD1
UNIVERSIDAD DE CASTILLA LA MANCHA1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITAET ULM1
UNIVERSITEIT GENT1
UNIVERSITY OF BEDFORDSHIRE1
UNIVERSITY OF WALES CARDIFF1
UNIVERZITA KARLOVA V PRAZE1
VRIJE UNIVERSITEIT BRUSSEL1

Constancy:

Total number of partners: 16
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 16
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2015-09-01EPIGEN: A New Predictive Response Test for Non Small Cells Lung Cancer Treatment EPIGENcoordinator50.0001
2012-03-01A RANDOMIZED CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF A MULTI-MODAL INTERVENTION IN OLDER PEOPLE WITH TYPE 2 DIABETES ON FRAILTY AND QUALITY OF LIFE: THE MID-FRAIL STUDY MID-FRAIL-STUDYparticipant5.975.82117